Both selective and dual PDE4 and PDE7 inhibitors were previously shown to be effective in MOG35–55-induced EAE [8,11], CIA [17,18], and ConA-induced hepatitis [38,39]. The gene discussed is PDE4A; the disease is hepatitis A virus infection.